<DOC>
	<DOCNO>NCT00334724</DOCNO>
	<brief_summary>The purpose study determine whether blood pressure control home blood pressure monitoring exert beneficial cardioprotective effect rather clinic blood pressure monitor elderly patient .</brief_summary>
	<brief_title>Home Blood Pressure-guided Antihypertensive Intervention Elderly ( HBP-GUIDE ) Study</brief_title>
	<detailed_description>Home blood pressure ( BP ) measurement report closely correlated target organ damage appear prognostic indicator respect cardiovascular mortality cardiovascular event . However , whether BP control home BP monitoring exerts cardioprotective effect rather clinic BP monitoring elderly patient remain unknown . In study , total 500 elderly patient diagnose essential hypertension randomly divide 2 group ; target BP level , home SBP &lt; 135 mmHg home DBP &lt; 85 mmHg ( home BP control group ) , clinic SBP &lt; 140 mmHg clinic DBP &lt; 90 mmHg ( clinic BP control group ) . Olmesartan dose 20 mg/day administer increase 40 mg , antihypertensive effect inadequate . Study visit make bimonthly least 1 year . The antihypertensive cardioprotective effect include systemic level C-reactive protein inflammatory cytokine , arterial stiffness compare two group .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Outpatients age 65 year less 80 year Patients stable seat systolic blood pressure ≥ 140 mmHg diastolic blood pressure ≥ 90 mmHg two visit within 8 week Patients stable seat systolic blood pressure ≥ 135 mmHg diastolic blood pressure ≥ 85 mmHg home ( home blood pressure measure every morning within 1 h waking , define mean 3 day measurement within 8 week ) Patients secondary hypertension malignant hypertension Patients stable seat systolic pressure ≥ 180 mmHg diastolic pressure ≥ 110 mmHg Patients renal dysfunction serum creatinine level ≥ 2 mg/dl Patients liver dysfunction Patients history hypersensitivity angiotensin II receptor blockade Patients history myocardial infarction within 6 month prior enrolment study Patients underwent coronary arterioplasty within 6 month prior enrolment study patient undergo coronary arterioplasty within 6 month entry Patients heart failure Patients history cerebrovascular disorder Other patient judge inappropriate study investigator</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Vascular disease</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Home blood pressure measurement</keyword>
</DOC>